Catalent Dividends and Buybacks
Dividend criteria checks 0/6
Catalent does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-0.08%
Buyback Yield
| Total Shareholder Yield | -0.08% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Catalent, Inc.'s (NYSE:CTLT) Share Price Not Quite Adding Up
Aug 30
Are Investors Undervaluing Catalent, Inc. (NYSE:CTLT) By 24%?
Jul 23Beyond Elevidys: Unveiling The Competitive Landscape Of Duchenne's Muscular Dystrophy
Jun 25Catalent - Novo Holdings Merger: Attractive Spread
Feb 07Catalent: Debt Remains An Overhang
Dec 13Catalent Remains Overvalued
Oct 04Calculating The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)
Aug 14Catalent: Myriad Issues To Fix
Jul 31Catalent (NYSE:CTLT) Has A Somewhat Strained Balance Sheet
May 05A Look At The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)
Mar 27Why did Catalent stock soar today? Potential takeover by Danaher
Feb 06We Think Catalent (NYSE:CTLT) Is Taking Some Risk With Its Debt
Feb 01Catalent to make Sarepta Therapeutics' muscle wasting gene therapy under supply deal
Jan 05An Intrinsic Calculation For Catalent, Inc. (NYSE:CTLT) Suggests It's 27% Undervalued
Dec 27Humanigen to pay Catalent Pharma $12M to settle supply agreement dispute
Dec 22Catalent falls after new short call from Glasshouse Research
Dec 08Catalent Q1 2023 Earnings Preview
Oct 31These 4 Measures Indicate That Catalent (NYSE:CTLT) Is Using Debt Extensively
Oct 26Catalent: Charting A Post-Covid Future
Oct 19Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if CTLT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CTLT's dividend payments have been increasing.
Dividend Yield vs Market
| Catalent Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (CTLT) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.3% |
| Industry Average (Pharmaceuticals) | 2.5% |
| Analyst forecast (CTLT) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate CTLT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CTLT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate CTLT's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CTLT has not reported any payouts.